Skip to main content
. 2013 Mar 11;13:219. doi: 10.1186/1471-2458-13-219

Table 3.

Comparison of changes in cardiovascular disease risk between intervention and control groups at 6-month follow-up

 
 N
 Baseline
 6-month
 Intervention vs. Control
      Mean ± S.D. Mean ± S.D. Difference P-valuea
Weight, kg
 Intervention
 251
 65.6 ± 8.0
 63.7 ± 8.2
 -0.93
 0.002
Control
 1037
 65.7 ± 8.3
 65.2 ± 8.6
BMI, kg/m2
 Intervention
 251
 25.8 ± 2.2
 25.1 ± 2.3
 -0.37
 0.004
Control
 1037
 25.6 ± 2.2
 25.4 ± 2.4
Waist, cm
 Intervention
 250
 90.9 ± 5.9
 88.5 ± 6.6
 -0.77
 0.129
Control
 1036
 90.3 ± 5.6
 89.6 ± 6.3
SBP, mmHg
 Intervention
 251
 133.7 ± 14.0
 130.8 ± 13.0
 -1.77
 0.212
Control
 1037
 134.8 ± 15.5
 133.0 ± 15.0
DBP, mmHg
 Intervention
 251
 80.0 ± 9.4
 77.4 ± 8.7
 -1.54
 0.092
Control
 1036
 80.4 ± 10.3
 79.3 ± 9.7
HDL-C, mg/dl
 Intervention
 251
 57.9 ± 15.2
 58.5 ± 15.1
 0.91
 0.267
Control
 1037
 56.8 ± 15.1
 56.6 ± 15.3
LDL-C, mg/dl
 Intervention
 250
 134.7 ± 30.1
 130. ± 30.3
 2.78
 0.227
Control
 1036
 131.9 ± 30.9
 129.4 ± 29.7
TG, mg/dl
 Intervention
 251
 141.1 ± 65.8
 130.8 ± 71.0
 -14.9
 0.150
Control
 1036
 158.8 ± 125.9
 148.2 ± 114.3
HbA1c,%
 Intervention
 251
 5.33 ± 0.43
 5.25 ± 0.38
 -0.05
 0.179
Control
 1033
 5.33 ± 0.62
 5.33 ± 0.57
Framingham risk score, score
 Intervention
 250
 14.0 ± 2.4
 13.9 ± 2.4
 -0.46
 0.002
Control
 1029
 13.9 ± 2.7
 13.9 ± 2.9
Mean 10-year CHD risk, %
 Intervention
 250
 9.1 ± 5.9
 8.9 ± 6.0
 -1.12
 0.001
  Control 1030 9.4 ± 6.2 9.6 ± 6.5    

BMI = body mass index, waist = waist circumference, SBP = systolic blood pressure, DBP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol, LDL-C = low-density lipoprotein cholesterol, TG = Triglycerides, HbA1c = Hemoglobin, CHD = coronary heart disease.

aby covariance analysis adjusted for baseline values, age, sex and intervention times.